German turkey breeder company shares its experience-based evaluation on four methods of avian metapneumovirus vaccine ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

Turkey growers are suffering losses from a disease that first appeared in the U.S. a year ago.  Iowa Turkey Federation executive director Gretta Irwin says poultry health is a concern for growers.

The live vaccine is produced from the strain Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN), an attenuated, non-replicating orthopoxvirus.

Many theories and studies describing the origin of the COVID-19 pandemic link it to laboratory experiments and natural human contact with animals.

While the ‘official’ flu season may still be a month or two away, reports indicate a rise in respiratory illnesses like the ...

Credit: NIAID NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies showed full protection, and the Phase 1 trial will assess ...

A group of researchers led by Sunil Mor, an associate professor at SDSU, is studying the subgroups A and B of the avian metapneumovirus to develop diagnostic testing to identify it and a vaccine.

USDA approved the first imported live vaccine in December 2024 and announced its decision to approve two more commercial modified live aMPV vaccines in late January 2025. The rollout process of ...

Clinical studies on the vaccine, called ChAd-triCoV/Mac, are currently underway. Phase one of human trails have been completed. “Most people now will have had COVID or had a vaccine or both. The work ...

The cause for his optimism was the fact that more than 182 million Americans had received at least one shot of the new COVID-19 vaccines, including nearly 90 percent of seniors and 70 percent of ...